Roche
ROG.SW
$274.16
Share price
0.30%
Change (1 day)
-17.36%
Change (1 year)
Categories
Roche (ROG.SW) - P/B ratio
P/B ratio as of October 2023 : 6.36
According to Roche's latest financial reports the company has a price-to-book ratio of 6.36.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Roche - P/B ratio (from 2006 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 8.56 | -26.2% |
| 2021-12-31 | 11.6 | 74.8% |
| 2020-12-31 | 6.63 | -11.14% |
| 2019-12-31 | 7.46 | 9.38% |
| 2018-12-31 | 6.82 | -5.4% |
| 2017-12-31 | 7.21 | -4.5% |
| 2016-12-31 | 7.55 | -25.29% |
| 2015-12-31 | 10.1 | -4.83% |
| 2014-12-31 | 10.6 | 6.79% |
| 2013-12-31 | 9.95 | -42.2% |
| 2012-12-31 | 17.2 | 80.35% |
| 2011-12-31 | 9.54 | -6.56% |
| 2010-12-31 | 10.2 | -37.55% |
| 2009-12-31 | 16.4 | 523.59% |
| 2008-12-31 | 2.62 | -18.49% |
| 2007-12-31 | 3.22 | -19.89% |
| 2006-12-31 | 4.02 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.33 | -16.13% | 🇺🇸 USA |
 Novartis NVS | 4.10 | -35.55% | 🇨🇭 Switzerland |
 Pfizer PFE | 1.79 | -71.84% | 🇺🇸 USA |
 Abbott Laboratories ABT | 4.57 | -28.04% | 🇺🇸 USA |
 Amgen AMGN | 21.4 | 236.13% | 🇺🇸 USA |
 Sanofi SNY | 1.69 | -73.41% | 🇫🇷 France |
 Becton Dickinson BDX | 2.94 | -53.76% | 🇺🇸 USA |
 Merck MRK | 5.64 | -11.22% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 4.90 | -22.90% | 🇬🇧 UK |